The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...